{"count": 3, "results": [{"_id": "37750649", "pmid": 37750649, "title": "Effect of Ezetimibe combined with Simvastatin in the treatment of coronary heart disease: a retrospective analysis.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Li B", "Li Y", "Peng WZ", "Liu YQ", "Xu ZS", "Wen JK"], "date": "2023-09-01T00:00:00Z", "doi": "10.26355/eurrev_202309_33581", "meta_date_publication": "2023 Sep", "meta_volume": "27", "meta_issue": "17", "meta_pages": "8212-8217", "score": 50276.504, "text_hl": "OBJECTIVE: The aim of this study was to explore the effect of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ combined with @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in the treatment of @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ (@<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@CHD@@@). ", "citations": {"NLM": "Li B, Li Y, Peng WZ, Liu YQ, Xu ZS, Wen JK. Effect of Ezetimibe combined with Simvastatin in the treatment of coronary heart disease: a retrospective analysis. Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):8212-8217. PMID: 37750649", "BibTeX": "@article{37750649, title={Effect of Ezetimibe combined with Simvastatin in the treatment of coronary heart disease: a retrospective analysis.}, author={Li B and Li Y and Peng WZ and Liu YQ and Xu ZS and Wen JK}, journal={Eur Rev Med Pharmacol Sci}, volume={27}, number={17}, pages={8212-8217}}"}}, {"_id": "24760119", "pmid": 24760119, "pmcid": "PMC4075313", "title": "Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy", "journal": "Braz J Med Biol Res", "authors": ["Camargo LM", "França CN", "Izar MC", "Bianco HT", "Lins LS", "Barbosa SP", "Pinheiro LF", "Fonseca FA"], "date": "2014-05-01T00:00:00Z", "doi": "10.1590/1414-431x20143628", "meta_date_publication": "2014 May", "meta_volume": "47", "meta_issue": "5", "meta_pages": "432-7", "score": 50073.07, "text_hl": "Effects of @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin/ezetimibe@@@ on microparticles, endothelial progenitor cells and @DISEASE_Blood_Platelet_Disorders @DISEASE_MESH:D001791 @@@platelet aggregation@@@ in subjects with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ under antiplatelet therapy", "citations": {"NLM": "Camargo LM, França CN, Izar MC, Bianco HT, Lins LS, Barbosa SP, Pinheiro LF, Fonseca FA. Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy Braz J Med Biol Res. 2014 May;47(5):432-7. PMID: 24760119", "BibTeX": "@article{24760119, title={Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy}, author={Camargo LM and França CN and Izar MC and Bianco HT and Lins LS and Barbosa SP and Pinheiro LF and Fonseca FA}, journal={Braz J Med Biol Res}, volume={47}, number={5}, pages={432-7}}"}}, {"_id": "17239888", "pmid": 17239888, "title": "Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study).", "journal": "Atherosclerosis", "authors": ["McKenney JM", "Jones PH", "Bays HE", "Knopp RH", "Kashyap ML", "Ruoff GE", "McGovern ME"], "date": "2007-06-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2006.11.037", "meta_date_publication": "2007 Jun", "meta_volume": "192", "meta_issue": "2", "meta_pages": "432-7", "score": 50045.785, "text_hl": "This was an open-label, multicenter, 12-week study in 292 @SPECIES_9606 @@@patients@@@ (50% @SPECIES_9606 @@@women@@@) who qualified for drug therapy based on number of @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@CHD@@@ risk factors. @SPECIES_9606 @@@Patients@@@ were randomized to four parallel arms, titrated from low to moderate or high doses: @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@/@CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@niacin@@@ @CHEMICAL_Erbium @CHEMICAL_MESH:D004871 @@@ER@@@, @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@/@CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@niacin@@@ @CHEMICAL_Erbium @CHEMICAL_MESH:D004871 @@@ER@@@, @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin/ezetimibe@@@, or @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ alone. ", "citations": {"NLM": "McKenney JM, Jones PH, Bays HE, Knopp RH, Kashyap ML, Ruoff GE, McGovern ME. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis. 2007 Jun;192(2):432-7. PMID: 17239888", "BibTeX": "@article{17239888, title={Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study).}, author={McKenney JM and Jones PH and Bays HE and Knopp RH and Kashyap ML and Ruoff GE and McGovern ME}, journal={Atherosclerosis}, volume={192}, number={2}, pages={432-7}}"}}]}